-
2
-
-
12444289448
-
Oral antihyperglycemic therapy for type 2 diabetes mellitus
-
Cheng AY, Fantus IG,. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ 2005; 172: 213-26.
-
(2005)
CMAJ
, vol.172
, pp. 213-226
-
-
Cheng, A.Y.1
Fantus, I.G.2
-
3
-
-
13644263258
-
Oral antidiabetic agents: Current role in type 2 diabetes mellitus
-
Krentz AJ, Bailey CJ,. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411.
-
(2005)
Drugs
, vol.65
, pp. 385-411
-
-
Krentz, A.J.1
Bailey, C.J.2
-
4
-
-
0033847575
-
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: Evidence for pharmacogenetics in diabetes
-
Pearson ER, Liddell WG, Shepherd M, et al. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000; 17: 543-5.
-
(2000)
Diabet Med
, vol.17
, pp. 543-545
-
-
Pearson, E.R.1
Liddell, W.G.2
Shepherd, M.3
-
5
-
-
84864285795
-
Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-96.
-
(2012)
Diabetologia
, vol.55
, pp. 1577-1596
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
6
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
7
-
-
79251612707
-
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
-
Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 2011; 43: 117-20.
-
(2011)
Nat Genet
, vol.43
, pp. 117-120
-
-
Zhou, K.1
Bellenguez, C.2
Spencer, C.C.3
-
8
-
-
84866319096
-
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: A replication and meta-Analysis of five cohorts
-
van Leeuwen N, Nijpels G, Becker ML, et al. A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-Analysis of five cohorts. Diabetologia 2012; 55: 1971-7.
-
(2012)
Diabetologia
, vol.55
, pp. 1971-1977
-
-
Van, L.N.1
Nijpels, G.2
Becker, M.L.3
-
9
-
-
84865457823
-
The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program
-
Florez JC, Jablonski KA, Taylor A, et al. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care 2012; 35: 1864-7.
-
(2012)
Diabetes Care
, vol.35
, pp. 1864-1867
-
-
Florez, J.C.1
Jablonski, K.A.2
Taylor, A.3
-
11
-
-
4544246587
-
Drug-gene interactions between genetic polymorphisms and antihypertensive therapy
-
Schelleman H, Stricker BH, De Boer A, et al. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004; 64: 1801-16.
-
(2004)
Drugs
, vol.64
, pp. 1801-1816
-
-
Schelleman, H.1
Stricker, B.H.2
De Boer, A.3
-
12
-
-
34547691356
-
Prime suspect: The TCF7L2 gene and type 2 diabetes risk
-
Hattersley AT,. Prime suspect: the TCF7L2 gene and type 2 diabetes risk. J Clin Invest 2007; 117: 2077-9.
-
(2007)
J Clin Invest
, vol.117
, pp. 2077-2079
-
-
Hattersley, A.T.1
-
13
-
-
34547702501
-
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
-
Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-63.
-
(2007)
J Clin Invest
, vol.117
, pp. 2155-2163
-
-
Lyssenko, V.1
Lupi, R.2
Marchetti, P.3
-
14
-
-
38349103468
-
Cytochrome P450 2C9 ∗2 and ∗3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus
-
Becker ML, Visser LE, Trienekens PH, et al. Cytochrome P450 2C9 ∗2 and ∗3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus. Clin Pharmacol Ther 2008; 83: 288-92.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 288-292
-
-
Becker, M.L.1
Visser, L.E.2
Trienekens, P.H.3
-
15
-
-
62749133967
-
Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: A preliminary study
-
Becker ML, Visser LE, van Schaik RH, et al. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 2009; 58: 745-9.
-
(2009)
Diabetes
, vol.58
, pp. 745-749
-
-
Becker, M.L.1
Visser, L.E.2
Van Schaik, R.H.3
-
16
-
-
0031663617
-
ATM: From gene to function
-
Rotman G, Shiloh Y,. ATM: from gene to function. Hum Mol Genet 1998; 7: 1555-63.
-
(1998)
Hum Mol Genet
, vol.7
, pp. 1555-1563
-
-
Rotman, G.1
Shiloh, Y.2
|